Serum Institute

Odisha receives 9,43,930 doses of #Covishield vaccine today; 1 lakh doses had arrived yesterday

Odisha Additional Chief Secretary (Health) Pradipta Kumar Mohapatra wrote a letter to the Serum Institute to supply 40 lakh doses of Covishield in May and 60 lakh doses per month from June.

Covishield Reaches Odisha On Tuesday. It is one of the first ever assignments for COVID 19 Vaccine.

Applications for the emergency use of Covid-19 vaccine by Serum Institute of India (SII) and Bharat Biotech are not rejected.

TNI Bureau:  India's first indigenous Covid-19 Vaccine, "COVAXIN" - developed by Bharat Biotech-ICMR, has been found to be safe without any adverse impacts in the Phase 1 trial. Phase 2 trials will begin in September. If all trials…

TNI Bureau: As part of the landmark collaboration between the Serum Institute of India (SII), Gavi, and Bill & Melinda Gates Foundation, the SII has announced that COVID-19 vaccine will be available at US$ 3 or Rs 225 per dose across 92…